Circulating microRNAs as biomarkers and mediators of platelet activation

References

• Bizzozero G. Su di un nuovo elemento morfologico del sangue dei mammiferi e della sua importanza nella trombosi e nella coagulazi- one. L’Osservatore 1881;17:785–787.
   Google Scholar
• Wright JH. The origin and nature of the blood plates. Bost Med Surg J 1906;154:643–645. doi:10.1056/NEJM190606071542301.
   Google Scholar
• Lefrançais E, Ortiz-Muñoz G, Caudrillier A, Mallavia B, Liu F, Sayah DM, Thornton EE, Headley MB, David T, Coughlin SR, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature 2017;544:105–109. doi:10.1038/nature21706.
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Skroblin P, Bender LH, Barwari T, Willeit P, Pechlaner R, Sunderland NP, Willeit K, Morton AC, Armstrong PC, et al. Association of MicroRNAs and YRNAs with platelet function. Circ Res 2016;118:420–432. doi:10.1161/CIRCRESAHA.114.305663.
   PubMed Web of Science ®Google Scholar
• Laffont B, Corduan A, Ple H, Duchez A-C, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2bulletmicroRNA complexes to endothelial cells via microparticles. Blood 2013;122:253–261. doi:10.1182/blood-2013-03-492801.
   PubMed Web of Science ®Google Scholar
• Sunderland N, Skroblin P, Barwari T, Huntley RP, Lu R, Joshi A, Lovering RC, Mayr M. MicroRNA biomarkers and platelet reactivity. Circ Res 2017;120:418–435. doi:10.1161/CIRCRESAHA.116.309303.
   PubMed Web of Science ®Google Scholar
• Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, et al. Circulating MicroRNAs as novel biomarkers for platelet activation. Circ Res 2013;112:595–600. doi:10.1161/CIRCRESAHA.111.300539.
   PubMed Web of Science ®Google Scholar
• Teruel-Montoya R, Kong X, Abraham S, Ma L, Kunapuli SP, Holinstat M, Shaw CA, McKenzie SE, Edelstein LC, Bray PF. MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression. PLoS One 2014;9:e102259. doi:10.1371/journal.pone.0102259.
   PubMed Web of Science ®Google Scholar
• Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 2011;117:5189–5197. doi:10.1182/blood-2010-09-299719.
   PubMed Web of Science ®Google Scholar
• Gutmann C, Joshi A, Zampetaki A, Mayr M. The landscape of coding and noncoding RNAs in platelets., antioxid. Redox Sig 2021;34:1200–1216. doi:10.1089/ars.2020.8139.
   PubMed Web of Science ®Google Scholar
• Dragomir MP, Knutsen E, Calin GA. SnapShot: unconventional miRNA functions. Cell 2018;174:1038–1038.e1. doi:10.1016/J.CELL.2018.07.040.
   PubMed Web of Science ®Google Scholar
• Lehmann SM, Krüger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 2012;15:827–835. doi:10.1038/nn.3113.
   PubMed Web of Science ®Google Scholar
• Park C-K, Xu -Z-Z, Berta T, Han Q, Chen G, Liu X-J, Ji -R-R. Extracellular MicroRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 2014;82:47–54. doi:10.1016/J.NEURON.2014.02.011.
   PubMed Web of Science ®Google Scholar
• Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012;109:E2110–6. doi:10.1073/pnas.1209414109.
   PubMed Web of Science ®Google Scholar
• Han Q, Liu D, Convertino M, Wang Z, Jiang C, Kim YH, Luo X, Zhang X, Nackley A, Dokholyan NV, et al. miRNA-711 binds and activates TRPA1 extracellularly to evoke acute and chronic pruritus. Neuron 2018;99:449–463.e6. doi:10.1016/J.NEURON.2018.06.039.
   PubMed Web of Science ®Google Scholar
• Stalder L, Heusermann W, Sokol L, Trojer D, Wirz J, Hean J, Fritzsche A, Aeschimann F, Pfanzagl V, Basselet P, et al. The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. EMBO J 2013;32:1115–1127. doi:10.1038/emboj.2013.52.
   PubMed Web of Science ®Google Scholar
• Flores O, Kennedy EM, Skalsky RL, Cullen BR. Differential RISC association of endogenous human microRNAs predicts their inhibitory potential. Nucleic Acids Res 2014;42:4629–4639. doi:10.1093/nar/gkt1393.
   PubMed Web of Science ®Google Scholar
• Yang D, Wan X, Dennis AT, Bektik E, Wang Z, Costa MGS, Fagnen C, Vénien-Bryan C, Xu X, Gratz DH, et al. MicroRNA biophysically modulates cardiac action potential by direct binding to ion channel. Circulation 2021;143:1597–1613. doi:10.1161/CIRCULATIONAHA.120.050098.
   PubMed Web of Science ®Google Scholar
• Flynn RA, Pedram K, Malaker SA, Batista PJ, Smith BAH, Johnson AG, George BM, Majzoub K, Villalta PW, Carette JE, et al. Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell 2021;184:3109–3124.e22. doi:10.1016/J.CELL.2021.04.023.
   PubMed Web of Science ®Google Scholar
• Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16:961–966. doi:10.1038/nsmb.1651.
   PubMed Web of Science ®Google Scholar
• Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, et al. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics 2013;14:1. doi:10.1186/1471-2164-14-1.
   PubMed Web of Science ®Google Scholar
• Osman A, Fälker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011;22:433–441. doi:10.3109/09537104.2011.560305.
   PubMed Web of Science ®Google Scholar
• Cimmino G, Tarallo R, Nassa G, De Filippo MR, Giurato G, Ravo M, Rizzo F, Conte S, Pellegrino G, Cirillo P, et al. Activating stimuli induce platelet microRNA modulation and proteome reorganisation. Thromb Haemost 2015;114:96–108. doi:10.1160/TH14-09-0726.
   PubMed Web of Science ®Google Scholar
• Elgheznawy A, Shi L, Hu J, Wittig I, Laban H, Pircher J, Mann A, Provost P, Randriamboavonjy V, Fleming I. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. Circ Res 2015;117:157–165. doi:10.1161/CIRCRESAHA.117.305784.
   PubMed Web of Science ®Google Scholar
• Fejes Z, Póliska S, Czimmerer Z, Káplár M, Penyige A, Gál Szabó G, Debreceni IB, Kunapuli SP, Kappelmayer J, Nagy B. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus. Thromb Haemost 2017;117:529–542. doi:10.1160/TH16-04-0322.
   PubMed Web of Science ®Google Scholar
• Shi R, Ge L, Zhou X, Ji W-J, Lu R-Y, Zhang -Y-Y, Zeng S, Liu X, Zhao J-H, Zhang W-C, et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res 2013;131:508–513. doi:10.1016/j.thromres.2013.02.015.
   PubMed Web of Science ®Google Scholar
• Peng L, Liu J, Qin L, Liu J, Xi S, Lu C, Yin T. Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS. Thromb Res 2017;157:97–102. doi:10.1016/j.thromres.2017.07.011.
   PubMed Web of Science ®Google Scholar
• Barwari T, Eminaga S, Mayr U, Lu R, Armstrong PC, Chan MV, Sahraei M, Fernández-Fuertes M, Moreau T, Barallobre-Barreiro J, et al. Inhibition of profibrotic microRNA-21 affects platelets and their releasate. JCI Insight 2018;3. doi:10.1172/jci.insight.123335.
   PubMed Web of Science ®Google Scholar
• Garcia A, Dunoyer-Geindre S, Zapilko V, Nolli S, Reny J-L, Fontana P. Functional validation of microRNA-126-3p as a platelet reactivity regulator using human haematopoietic stem cells. Thromb Haemost 2019;119:254–263. doi:10.1055/s-0038-1676802.
   PubMed Web of Science ®Google Scholar
• Wendel Garcia PD, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, Schuepbach RA, Hilty MP. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine 2020;100449. doi:10.1016/J.ECLINM.2020.100449.
   PubMedGoogle Scholar
• Schober A, Nazari-Jahantigh M, Wei Y, Bidzhekov K, Gremse F, Grommes J, Megens RTA, Heyll K, Noels H, Hristov M, et al. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat Med 2014;20:368–376. doi:10.1038/nm.3487.
   PubMed Web of Science ®Google Scholar
• Zapilko V, Fish RJ, Garcia A, Reny J-L, Dunoyer-Geindre S, Lecompte T, Neerman-Arbez M, Fontana P. MicroRNA-126 is a regulator of platelet-supported thrombin generation. Platelets 2020;31:746–755. doi:10.1080/09537104.2020.1775804.
   PubMed Web of Science ®Google Scholar
• La Rosa G, Biasucci LM, Mandolini C, Massimi I, Copponi G, Pulcinelli FM, Crea F. Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment. J Cardiovasc Med 2018;19:611–613. doi:10.2459/JCM.0000000000000691.
   Google Scholar
• Garcia A, Dunoyer-Geindre S, Nolli S, Strassel C, Reny J-L, Fontana P. miR-204-5p and platelet function regulation: insight into a mechanism mediated by CDC42 and GPIIbIIIa. Thromb Haemost 2021. doi:10.1055/a-1497-9649.
   Web of Science ®Google Scholar
• Liu J, Qin L, Wang Z, Peng L, Liu J, Wang X, Du R, Zou Y, Wu Y, Yin T. Platelet-derived miRNAs as determinants of the antiplatelet response in clopidogrel-treated patients with ACS. Thromb Res 2020;186:71–74. doi:10.1016/j.thromres.2019.12.016.
   PubMed Web of Science ®Google Scholar
• Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost 2010;8:369–378. doi:10.1111/j.1538-7836.2009.03700.x.
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee M-LT, Schmittgen TD, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694. doi:10.1371/journal.pone.0003694.
   PubMed Web of Science ®Google Scholar
• Tsui NBY, Ng EKO, Lo YMD. Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48;2002:1647–1653. [accessed August 24, 2019]. http://www.ncbi.nlm.nih.gov/pubmed/12324479
   PubMed Web of Science ®Google Scholar
• Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JBM, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93:633–644. doi:10.1093/cvr/cvs007.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard J-M, Mayr A, Weger S, Schett G, Shah A, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012;60:290–299. doi:10.1016/j.jacc.2012.03.056.
   PubMed Web of Science ®Google Scholar
• de Boer HC, van Solingen C, Prins J, Duijs JMGJ, Huisman MV, Rabelink TJ, van Zonneveld AJ. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 2013;34:3451–3457. doi:10.1093/eurheartj/eht007.
   PubMed Web of Science ®Google Scholar
• Chyrchel B, Totoń-Żurańska J, Kruszelnicka O, Chyrchel M, Mielecki W, Kołton-Wróż M, Wołkow P, Surdacki A. Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: a preliminary report. Platelets 2015;26:593–597. doi:10.3109/09537104.2014.974527.
   PubMed Web of Science ®Google Scholar
• Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, Schmitz T, Dolf A, Endl E, Franklin BS, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc 2014;3:e001249. doi:10.1161/JAHA.114.001249.
   PubMed Web of Science ®Google Scholar
• Carino A, De Rosa S, Sorrentino S, Polimeni A, Sabatino J, Caiazzo G, Torella D, Spaccarotella C, Mongiardo A, Strangio A, et al. Indolfi, modulation of circulating MicroRNAs levels during the switch from clopidogrel to ticagrelor. Biomed Res Int 2016 ;2016:1–5. doi:10.1155/2016/3968206.
   Web of Science ®Google Scholar
• Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, Devaux Y, Katan M. MicroRNA 150-5p improves risk classification for mortality within 90 days after acute ischemic stroke. J Stroke 2017;19:323–332. doi:10.5853/jos.2017.00423.
   PubMed Web of Science ®Google Scholar
• Jäger B, Stojkovic S, Haller PM, Piackova E, Kahl BS, Andric T, Vargas KG, Wojta J, Huber K. Course of platelet miRNAs after cessation of P2Y12 antagonists. Eur J Clin Invest 2019;49:e13149. doi:10.1111/eci.13149.
   PubMed Web of Science ®Google Scholar
• Parker WAE, Schulte C, Barwari T, Phoenix F, Pearson SM, Mayr M, Grant PJ, Storey RF, Ajjan RA. Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovasc Diabetol 2020;19:3. doi:10.1186/s12933-019-0981-3.
   PubMed Web of Science ®Google Scholar
• Becker KC, Kwee LC, Neely ML, Grass E, Jakubowski JA, Fox KAA, White HD, Gregory SG, Gurbel PA, de P. Carvalho L, et al. Circulating MicroRNA profiling in non-ST elevated coronary artery syndrome highlights genomic associations with serial platelet reactivity measurements. Sci Rep 2020;10:6169. doi:10.1038/s41598-020-63263-6.
   PubMed Web of Science ®Google Scholar
• Braza-Boïls A, Barwari T, Gutmann C, Thomas MR, Judge HM, Joshi A, Pechlaner R, Shankar-Hari M, Ajjan RA, Sabroe I, et al. Circulating MicroRNA levels indicate platelet and leukocyte activation in endotoxemia despite platelet P2Y12 inhibition. Int J Mol Sci 2020;21:2897. doi:10.3390/ijms21082897.
   Web of Science ®Google Scholar
• Heber S, Laky M, Anscheringer I, Wolschner L, Mussbacher M, Krammer T, Haririan H, Schrottmaier WC, Volf I, Hackl M, et al. Platelet activation is not always associated with platelet-related plasma microRNA abundance – results from a randomized controlled trial of periodontal patients. Front Physiol 2021;12:191. doi:10.3389/fphys.2021.613515.
   Web of Science ®Google Scholar
• Gutmann C, Khamina K, Theofilatos K, Diendorfer AB, Burnap SA, Nabeebaccus A, Fish M, McPhail MJW, O’Gallagher K, and Schmidt LE, et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc Res 2022;118(2):461-474. doi:10.1093/cvr/cvab338.
   PubMed Web of Science ®Google Scholar
• Rounge TB, Umu SU, Keller A, Meese E, Ursin G, Tretli S, Lyle R, Langseth H. Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity. Sci Rep 2018;8:17650. doi:10.1038/s41598-018-35974-4.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E, et al. Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and other MicroRNAs in type 2 diabetes. Circ Res 2010;107:810–817. doi:10.1161/CIRCRESAHA.110.226357.
   PubMed Web of Science ®Google Scholar
• Sangiao-Alvarellos S, Theofilatos K, Barwari T, Gutmann C, Takov K, Singh B, Juiz-Valiña P, Varela-Rodríguez BM, Outeiriño-Blanco E, Duregotti E, et al. Metabolic recovery after weight loss surgery is reflected in serum microRNAs. BMJ Open Diabetes Res Care 2020;8:e001441. doi:10.1136/bmjdrc-2020-001441.
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Lee R, Willeit P, McGregor R, Markus HS, Kiechl S, Zampetaki A, Storey RF, Channon KM, Mayr M. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost 2013;110:609–615. doi:10.1160/TH13-05-0368.
   PubMed Web of Science ®Google Scholar
• Schulte C, Barwari T, Joshi A, Theofilatos K, Zampetaki A, Barallobre-Barreiro J, Singh B, Sörensen NA, Neumann JT, Zeller T, et al. Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury. Circ Res 2019;125:328–340. doi:10.1161/CIRCRESAHA.119.314937.
   PubMed Web of Science ®Google Scholar
• Lacroix R, Judicone C, Poncelet P, Robert S, Arnaud L, Sampol J, Dignat-George F. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J Thromb Haemost 2012;10:437–446. doi:10.1111/j.1538-7836.2011.04610.x.
   PubMed Web of Science ®Google Scholar
• György B, Pálóczi K, Kovács A, Barabás E, Bekő G, Várnai K, Pállinger É, Szabó-Taylor K, Szabó TG, Kiss AA, et al. Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube. Thromb Res 2014;133:285–292. doi:10.1016/j.thromres.2013.11.010.
   PubMed Web of Science ®Google Scholar
• Lelliott PM, Momota M, Shibahara T, Lee MSJ, Smith NI, Ishii KJ, Coban C. Heparin induces neutrophil elastase-dependent vital and lytic NET formation. Int Immunol 2020;32:359–368. doi:10.1093/intimm/dxz084.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64. doi:10.1186/gb-2009-10-6-r64.
   PubMed Web of Science ®Google Scholar
• da S. Maués JH, de F. Aquino Moreira-nunes C, Rodriguez Burbano RM. MicroRNAs as a potential quality measurement tool of platelet concentrate stored in blood banks-a review. Cells 2019;8. doi:10.3390/cells8101256.
   Web of Science ®Google Scholar
• Pontes TB, de F.a. Moreira-nunes C, da S. Maués JH, Lamarão LM, de Lemos JAR, Montenegro RC, Burbano RMR. The miRNA profile of platelets stored in a blood bank and its relation to cellular damage from storage. PLoS One 2015;10:e0129399. doi:10.1371/journal.pone.0129399.
   PubMed Web of Science ®Google Scholar
• Joshi A, Schmidt LE, Burnap SA, Lu R, Chan MV, Armstrong PC, Baig F, Gutmann C, Willeit P, Santer P, et al. Neutrophil-derived protein S100A8/A9 alters the platelet proteome in acute myocardial infarction and is associated with changes in platelet reactivity. Arterioscler Thromb Vasc Biol 2021;ATVBAHA121317113. doi:10.1161/ATVBAHA.121.317113.
   Web of Science ®Google Scholar
• Aradi D, Storey RF, Komócsi A, Trenk D, Gulba D, Kiss RG, Husted S, Bonello L, Sibbing D, Collet J-P, et al., Working Group on Thrombosis of the European Society of Cardiology. Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. Eur Heart J 2014;35:209–215. doi:10.1093/eurheartj/eht375.
   PubMed Web of Science ®Google Scholar